NCT02156076 A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation Status TERMINATED Phase PHASE2
NCT02153437 Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers Status TERMINATED Phase PHASE1
NCT02142218 Expanded Access Program With Nivolumab to Treat Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02134288 Belatacept for Renal Transplant Recipients With Delayed Graft Function Status TERMINATED Phase EARLY_PHASE1
NCT02130817 Belatacept in Kidney Transplantation of Moderately Sensitized Patients Status WITHDRAWN Phase PHASE4
NCT02124044 Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV Status COMPLETED Phase PHASE2
NCT02123654 UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C Status COMPLETED Phase PHASE3
NCT02115139 GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases Status COMPLETED Phase PHASE2
NCT02113657 T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02110082 Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02109666 Long Term Experience With Abatacept in Routine Clinical Practice Status COMPLETED Phase N/A
NCT02108860 Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Status COMPLETED Phase PHASE3
NCT02108639 To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet Status COMPLETED Phase PHASE1
NCT02107755 Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT02107365 Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO) Status COMPLETED Phase PHASE2
NCT02105636 Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) Status COMPLETED Phase PHASE3
NCT02104843 Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin Status COMPLETED Phase PHASE1